AB Science announces that results from masitinib study AB07015 in severe asthma have been selected for presentation at an ATS symposium held on 16th October, 2020

    NEXT STORY
    Ballad Health Chairman and CEO Joins National Healthcare Leaders in Joint Commitment to Transform Healthcare System
    PREV STORY
    RedHill Biopharma Announces Partnerships to Expand Manufacturing for COVID-19 Therapeutic Candidate Opaganib
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    SpringWorks Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

    author_avatar
    NASDAQ Market News

    SciCann Therapeutics reports positive pre-clinical results for proprietary CBD combination product

    TORONTO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- SciCann Therapeutics Inc reports today positive results ...

    author_avatar
    NASDAQ Market News

    Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow

    ALPHARETTA, Ga., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News